Skin autografts in epidermodysplasia verruciformis: Human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion

Cancer Research

Volumn 57, Issue 19, 1997, Pages 4214-4216

  Majewski, Slawomir ^a   Jablonska, Stefania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOGRAFT; CANCER RISK; CLINICAL ARTICLE; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMAN; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN CARCINOGENESIS; SKIN CARCINOMA; VERRUCA VULGARIS; VIRUS VIRULENCE;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS; SKIN TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TUMOR VIRUS INFECTIONS;

EID: 0030841557     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jablonska, S., Dabrowski, J., and Jakubowicz, K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res., 30: 583-589, 1972.
2. Orth, G., Jablonska, S., Favre, M., Croissant, O., Jarzabek-Chorzelska, M., and Rzesa, G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc. Natl. Acad. Sci. USA, 75: 1537-1541, 1978.
3. Orth, G., Jablonska, S., Jarzabek-Chorzelska, M., Obalek, S., Rzesa, G., Favre, M., and Croissant, O. Characteristics of the lesions and risk of malignant conversion as related to the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res., 39: 1074-1082, 1979.
4. Jablonska, S., and Majewski, S. Epidermodysplasia verruciformis. Curr. Opin. Dermatol., 4: 63-70, 1997.
5. Shamanin, V., Glover, M., Rausch, C., Proby, C., Leigh, I. M., zur Hausen, H., and de Villiers, E-M. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res., 54: 4610-4613, 1994.
6. Shamanin, V., zur Hausen, H., Lavergne, D., Proby, C., Leigh, I. M., Neumann, C., Hamm, H., Goss, M., Haustein, U-F., Jung, E. G., Plewig, G., Wolff, H., and de Villiers, E-M. HPV infections in non-melanoma skin cancers from renal transplant recipients and non-immunosuppressed patients. J. Natl. Cancer Inst., 88: 802-811, 1996.
7. Berkhout, R. J., Tieben, L. M., Smits, H. I. Bouves-Bavinck, J. N., Vermeer, B. J., and Schegget, J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J. Clin. Microbiol., 33: 690-695, 1995.
8. Tieben, I. M., Berkhout, R. J. M., Smits, H. L., Bouves-Bavinck, J. N., Vermeer, B. J., Bruijn, J. A., van der Wunde, F. J., and ter Schegget, J. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant lesions of renal transplant recipients. Br. J. Dermatol., 131: 226-230, 1994.
9. Orth, G. Epidermodysplasia verruciformis. In: N. P. Salzman and P. M. Howley (eds.), The Papovaviriden, Vol. 2. The papillomaviruses, pp. 199-243. New York: Plenum Publishing Corp., 1987.
10. Schiffman, M. H. Epidemiology of cervical human papillomaviruses. In: H. zur Hausen (ed.) Human pathogenic papillomaviruses. Curr. Top. Microbiol. Immunol., 186: 55-81, 1994.
11. de Villiers, E-M., Wagner, D., Schneider, A., Wesch, H., Miklow, H., Wahrendorf, J., Papendick, U., and zur Hausen, H. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet, ii: 703-706, 1987.
12. de Villiers, E-M., Wagner, D., Schneider, A., Wesch, H., Munz, F., Micklaw, H., and zur Hausen, H. Human papillomavirus DNA in women without and with cytological abnormalities: results of a five-year follow-up study. Gynecol. Oncol., 44: 33-39, 1992.
13. zur Hausen, H. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet, ii: 489-491, 1986.
14. zur Hausen, H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta, 1288: F55-F78, 1996.
15. Boxman, I. L. A., Berkhout, R. J. M., Mulder, L. H. C., Wolkers, M. C., Bouves-Bavinck, J. N., Vermeer, B. J., and ter Schegget, J. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J. Invest. Dermatol., 108: 712-715, 1997.
16. Deau, M-C., Favre, M., Jablonska, S., Rueda, L-A., and Orth, G. Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J. Clin. Microbiol., 31: 2918-2926, 1993.
17. Kawase, M., Orth, G., Jablonska, S., Blanchet-Bardon, C., Rueda, U-A., and Favre, M. Variability and phylogeny of the L1 capsid protein gene of human papillomavirus type 5. Contribution of clusters of nonsynonymous mutations and a 30-nucleotide duplication. Virology, 221: 189-198, 1996.
18. Majewski, S., and Jablonska, S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch. Dermatol., 131: 1312-1318, 1995.
19. th International Papillomavirus Conference, Quebec, Abstract Book, pp. 198, 1995.
20. Majewski, S., Hunzelmann, N., Nischt, R., Eckes, B., Rudnicka, L., Orth, G., Krieg, T., and Jablonska, S. TGFβ-1 and TNFα expression in the epidermis of patients with epidermodysplasia verruciformis. J. Invest. Dermatol., 97: 862-867, 1991.
21. Pierce, D. F., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., Jr., and Moses, H. L. Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA, 92: 4254-4258, 1995.
22. Glick, A. B., Lee, M. M., Darwiche, N., Kulkarni, A. B., Karlsson, S., and Yuspa, S. H. Targeted depletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes Dev., 8: 2429-2440, 1994.
23. Factor, V. M., Kao, C-Y., Santoni-Rugiu, E., Woitach, J. T., Jensen, M. R., and Thorgeirsson, S. S. Constitutive expression of mature transforming growth factor β1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res., 57: 2089-2095, 1997.
24. Missero, C., Ramon Y Cajal, S., and Dotto, G. P. Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc. Natl. Acad. Sci. USA, 88: 9613-9617, 1991.
25. Braun, L., Durst, M., Mikumo, R., and Gruppuso, P. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor β1. Cancer Res., 50: 7324-7332, 1990.
26. Gross, G., Ellinger, K., Roussaki, A., Fuchs, P. G., Peter, H. H., and Pfister, H. Epidermodysplasia verruciformis in a patient with Hodgkin's disease. Characterization of a new papillomavirus type and interferon treatment. J. Invest. Dermatol., 91: 43-48, 1988.